These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10070760)

  • 1. Backbone and C beta assignments of the anti-gp120 antibody Fv fragment complexed with an antigenic peptide.
    Tugarinov V; Levy R; Dahan-Schokoroy A; Anglister J
    J Biomol NMR; 1999 Feb; 13(2):193-4. PubMed ID: 10070760
    [No Abstract]   [Full Text] [Related]  

  • 2. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
    Tugarinov V; Zvi A; Levy R; Anglister J
    Nat Struct Biol; 1999 Apr; 6(4):331-5. PubMed ID: 10201400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
    Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
    Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies of human HIV-1 V3 antibodies.
    Stanfield RL; Wilson IA
    Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
    Zvi A; Tugarinov V; Faiman GA; Horovitz A; Anglister J
    Eur J Biochem; 2000 Feb; 267(3):767-79. PubMed ID: 10651813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential.
    Fontenot JD; VanCott TC; Parekh BS; Pau CP; George JR; Birx DL; Zolla-Pazner S; Gorny MK; Gatewood JM
    AIDS; 1995 Oct; 9(10):1121-9. PubMed ID: 8519447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
    Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
    Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping antibody-antigen complexes by nuclear magnetic resonance spectroscopy.
    Kustanovich I; Zvi A
    Methods Mol Biol; 1996; 66():25-37. PubMed ID: 8959701
    [No Abstract]   [Full Text] [Related]  

  • 13. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
    Harrop HA; Coombe DR; Rider CC
    AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
    Tsang P; Mu X; Wu G; Durda PJ
    J Mol Recognit; 1997; 10(6):256-61. PubMed ID: 9770649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the principal neutralization site of HIV-1.
    Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
    Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions.
    Zvi A; Kustanovich I; Hayek Y; Matsushita S; Anglister J
    FEBS Lett; 1995 Jul; 368(2):267-70. PubMed ID: 7543061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
    Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
    Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of arginine residues in the RP135 peptide derived from the V3 loop of gp120 to its interaction with the Fv fragment of the 0.5beta HIV-1 neutralizing antibody.
    Faiman GA; Levy R; Anglister J; Horovitz A
    J Biol Chem; 1996 Jun; 271(23):13829-33. PubMed ID: 8662780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of a glycoprotein 120 V3 loop peptide to HIV-1 neutralizing antibodies. Structural implications.
    Wu G; MacKenzie R; Durda PJ; Tsang P
    J Biol Chem; 2000 Nov; 275(47):36645-52. PubMed ID: 10967109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.